TRXB

NASD TRex Bio, Inc.
Oct 12, 2026 · 6:01 AM ET LAST TRADE Market Closed

$13.47 ↓ -0.53 (-3.79%) Trading Down from the previous close of $14.00

YTD change
-3.79%
vs 20-day SMA
N/A
vs 200-day SMA
N/A

Price ranges

Previous day
$13.50 $15.50
open $13.50 close $14.00
+$0.50 (+3.70%)
Today
$0.00 $0.00
$13.47
Past week
$0.00 $14.00
from $14.00 now $13.47
-$0.53 (-3.79%)
Past month
$0.00 $14.00
from $14.00 now $13.47
-$0.53 (-3.79%)
This year
$13.50 $15.50
from $14.00 now $13.47
-$0.53 (-3.79%)

Price & Performance

+0.00 (+0.00%) / 6M

No chart data available

Signals & Sentiment

Momentum, market sentiment, and recent alerts

N/A
  • The stock is 13.1% away from all-time highs of $15.50
  • TRXB is down 4% since the beginning of the year
  • TRXB is down 4% over the past 12 months
  • TRXB is down 4% over the past 1 month

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable N/A
EPS N/A
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$67.7M
Debt$717.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Market cap $369.7M

TRexBio is a biotechnology company that leverages cutting-edge computational biology tools, a focus on human tissue, and expertise in immunobiology to develop therapeutics for cancer and inflammatory diseases. Its 'deep biology' discovery engine maps human tissue Treg behavior to disease processes, identifying and characterizing novel targets for therapeutic intervention. The platform supports the development of a portfolio of therapies that modulate the immune system to restore tissue immune homeostasis.

Competitor comparison

No peer group available for this symbol.

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.